BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Open to More M&A Deals


5/16/2012 7:22:29 AM

After spending nearly $15 billion on overseas acquisitions in less than two years, Japan's top drug maker Takeda Pharmaceutical Co. is not ruling out further deals as it looks to overcome patent expiries and cement its position as a global industry player. "We will be looking for those things that are a very good fit with what we have already put in place," Anna Protopapas, a corporate officer at Takeda who oversees the company's global M&A functions, said in a recent interview. Protopapas helped to engineer Takeda's $13.7 billion purchase of Swiss drug maker Nycomed last year--the second-biggest foreign purchase ever by a Japanese firm--and led a $800 million all-cash deal to buy Philadelphia-based URL Inc. that was announced in April.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->